Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy

[Pyr 1 ]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart

(2009) Janet J. Maguire et al.   HYPERTENSION

Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload

(2009) Olivier Lairez et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Apelin protects heart against ischemia/reperfusion injury in rat

(2009) Xiang Jun Zeng et al.   PEPTIDES

The apelin–APJ system in heart failure

(2008) Alan G. Japp et al.   BIOCHEMICAL PHARMACOLOGY

Catalase and glutathione peroxidase mimics

(2008) Brian J. Day   BIOCHEMICAL PHARMACOLOGY

Mitochondrial oxidative stress and dysfunction in myocardial remodelling

(2008) H. Tsutsui et al.   CARDIOVASCULAR RESEARCH

Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice

(2008) Cédric Dray et al.   Cell Metabolism

The role of apelin in cardiovascular function and heart failure

(2008) Badrinathan Chandrasekaran et al.   EUROPEAN JOURNAL OF HEART FAILURE

Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase

(2008) Bettina Johanna Stuck et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Down-regulation of Catalase and Oxidative Modification of Protein Kinase CK2 Lead to the Failure of Apoptosis Repressor with Caspase Recruitment Domain to Inhibit Cardiomyocyte Hypertrophy

(2008) Iram Murtaza et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase

(2007) Matthias J. Kleinz et al.   REGULATORY PEPTIDES